Erectile Function Outcome Reporting After Clinically Localized Prostate Cancer Treatment
Arthur L. Burnett(Johns Hopkins University), Ian M. Thompson(The University of Texas at San Antonio Health Science Center), Jeffrey D. Forman(Wayne State University), Catherine M. Tangen(American Urological Association), Judd W. Moul(General Marble (Greece)), Roger R. Dmochowski(Vanderbilt University Medical Center), Edith Canby‐Hagino(American Urological Association), Monica Liebert(Ann Arbor Center for Independent Living), Michael S. Cookson(University of Oklahoma Health Sciences Center), Anthony V. D’Amico(Brigham and Women's Hospital), S. Larry Goldenberg(University of British Columbia), David T. Eton(Mayo Clinic), Stephen R. Kraus(The University of Texas at San Antonio Health Science Center), Gunnar Aus(American Urological Association), Celestia S. Higano(University of British Columbia), J. Brantley Thrasher(American Urological Association), Javier Hernández(Vall d'Hebron Hospital Universitari)
Cited by 212
Related Papers
Frailty in Older Adults: Evidence for a Phenotype
|The Journals of Gerontology Series A|2001|24.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Patient engagement in research: a systematic review
|BMC Health Services Research|2014|1.8k